SFX by Ex Libris Inc.

Title:	Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Source:	Nature Medicine [1078-8956] Sistigu, Antonella yr:2014

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gatti, G. "Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-Î² production capable of improving dendritic cell function." European Journal of Immunology 43.7 (2013): 1849-1861.
description	2.	Dudek, Aleksandra M. "Inducers of immunogenic cancer cell death." Cytokine & growth factor reviews 24.4 (2013): 319-333.
description	3.	Galluzzi, L. "The secret ally: immunostimulation by anticancer drugs." Nature reviews. Drug discovery 11.3 (2012): 215-233.
description	4.	Burnette, B. "The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity." Cancer research 71.7 (2011): 2488-2496.
description	5.	Hedayat, M. "Prophylactic and therapeutic implications of toll-like receptor ligands." Medicinal research reviews 32.2 (2010): 294-325.
description	6.	Galluzzi, L. "Immunogenic cell death in cancer and infectious disease." Nature Reviews. Immunology 17.2 (2016): 97-111.
description	7.	Krysko, Dmitri V. "Immunogenic cell death and DAMPs in cancer therapy." Nature Reviews. Cancer 12.12 (2012): 860-875.
description	8.	Verfaillie, T. "Pro-apoptotic signaling induced by photo-oxidative ER stress is amplified by Noxa, not Bim." Biochemical and biophysical research communications 438.3 (2013): 500-506.
description	9.	Laurence Zitvogel, Guido Kroemer; Laurence Zitvogel, Guido Kroemer;, G. "Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects." Journal of Clinical Investigation 119.8 (2009): 2127-30.
description	10.	Kroemer, G. "Immunogenic cell death in cancer therapy." Annual review of immunology 31.1 (2013): 51-72.
description	11.	Choi, Hye Joung J. "Targeting interferon response genes sensitizes aromatase inhibitor resistant breast cancer cells to estrogen-induced cell death." Breast cancer research 17 (2015): 6-6.
description	12.	Riccioli, A. "Transfected poly(I:C) activates different dsRNA receptors leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells." Journal of biological chemistry 290.9 (2015): 5470-83.
description	13.	Sistigu, A. "Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy." Nature medicine 20.11 (2014): 1301-9.
description	14.	Bodogai, M. "Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L." Cancer research 73.7 (2013): 2127-2138.
description	15.	Liu, W. "RADIOTHERAPY ALONE WITH CURATIVE INTENT IN PATIENTS WITH STAGE I EXTRANODAL NASAL-TYPE NK/T-CELL LYMPHOMA." International journal of radiation oncology, biology, physics 82.5 (2012): 1809-1815.
description	16.	Matesic, D. "Modulating Toll-like Receptor 7 and 9 Responses as Therapy for Allergy and Autoimmunity." Current allergy and asthma reports 12.1 (2011): 8-17.
description	17.	Apetoh, L. "Harnessing dendritic cells in cancer." Seminars in immunology 23.1 (2011): 42-49.
description	18.	Levitzki, A. "Signal transduction therapy of cancer." Molecular aspects of medicine 31.4 (2010): 287-329.
description	19.	Cario, E. "Toll-like receptors in inflammatory bowel diseases: a decade later." Inflammatory bowel diseases 16.9 (2010): 1583-1597.
description	20.	Ma, Y. "Chemotherapy and radiotherapy: Cryptic anticancer vaccines." Seminars in immunology 22.3 (2010): 113-124.